,54,81,82,93,94 However, patients with low SNHG2 expression had shorter overall survival and progression free survival, and the expression level of SNHG2 was negatively associated with tumor size, depth of invasion and clinical staging, suggesting that SNHG2 could be an indicator of good prognosis of ovarian cancer.80 This evidence concerns the gene GAS5 and ovarian carcinoma.